Authors' Response to: Prophylactic Fentanyl Sublingual Spray for Episodic Exertional Dyspnea in Cancer Patients: A Pilot Double-Blind Randomized Controlled Trial.
作者信息
Hui David, Bruera Eduardo
机构信息
Department of Palliative Care, Rehabilitation and Integrative Medicine, MD Anderson Cancer Center, Houston, Texas, USA.
Department of Palliative Care, Rehabilitation and Integrative Medicine, MD Anderson Cancer Center, Houston, Texas, USA.
出版信息
J Pain Symptom Manage. 2019 Oct;58(4):e17-e18. doi: 10.1016/j.jpainsymman.2019.07.019. Epub 2019 Jul 26.
Abstract
摘要
相似文献
1
Authors' Response to: Prophylactic Fentanyl Sublingual Spray for Episodic Exertional Dyspnea in Cancer Patients: A Pilot Double-Blind Randomized Controlled Trial.
J Pain Symptom Manage. 2019 Oct;58(4):e17-e18. doi: 10.1016/j.jpainsymman.2019.07.019. Epub 2019 Jul 26.
2
Response to "Prophylactic Fentanyl Sublingual Spray for Episodic Exertional Dyspnea in Cancer Patients: A Pilot Double-Blind Randomized Controlled Trial".
J Pain Symptom Manage. 2019 Oct;58(4):e16-e17. doi: 10.1016/j.jpainsymman.2019.07.020. Epub 2019 Jul 26.
3
Prophylactic Fentanyl Sublingual Spray for Episodic Exertional Dyspnea in Cancer Patients: A Pilot Double-Blind Randomized Controlled Trial.
J Pain Symptom Manage. 2019 Oct;58(4):605-613. doi: 10.1016/j.jpainsymman.2019.06.024. Epub 2019 Jul 2.
4
Effect of Prophylactic Fentanyl Buccal Tablet on Episodic Exertional Dyspnea: A Pilot Double-Blind Randomized Controlled Trial.
J Pain Symptom Manage. 2017 Dec;54(6):798-805. doi: 10.1016/j.jpainsymman.2017.08.001. Epub 2017 Aug 10.
5
Impact of Prophylactic Fentanyl Pectin Nasal Spray on Exercise-Induced Episodic Dyspnea in Cancer Patients: A Double-Blind, Randomized Controlled Trial.
J Pain Symptom Manage. 2016 Oct;52(4):459-468.e1. doi: 10.1016/j.jpainsymman.2016.05.013. Epub 2016 Jul 9.
6
Efficacy and safety of fentanyl sublingual spray for the treatment of breakthrough cancer pain: a randomized, double-blind, placebo-controlled study.
Curr Med Res Opin. 2012 May;28(5):859-70. doi: 10.1185/03007995.2012.683111. Epub 2012 May 2.
7
Lack of correlation between the effective dose of fentanyl sublingual spray for breakthrough cancer pain and the around-the-clock opioid dose.
J Opioid Manag. 2014 Jul-Aug;10(4):247-54. doi: 10.5055/jom.2014.0212.
8
Long-term safety of fentanyl sublingual spray in opioid-tolerant patients with breakthrough cancer pain.
Support Care Cancer. 2016 Jun;24(6):2669-75. doi: 10.1007/s00520-015-3056-3. Epub 2016 Jan 16.
9
Does nebulized fentanyl relieve dyspnea during exercise in healthy man?
J Appl Physiol (1985). 2015 Jun 1;118(11):1406-14. doi: 10.1152/japplphysiol.01091.2014. Epub 2015 Mar 12.
10
Intranasal Fentanyl Versus Placebo for Treatment of Episodic Breathlessness in Hospice Patients With Advanced Nonmalignant Diseases.
J Pain Symptom Manage. 2021 May;61(5):1035-1041. doi: 10.1016/j.jpainsymman.2020.11.003. Epub 2020 Nov 10.
Zotero 插件